The longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy
Epilepsy & Behavior · 2024
DOI: 10.1016/j.yebeh.2023.109606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Ayushe A Sharma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA; Department of Neurobiology, University of Alabama at Birming…. Hauptthemen laut MEDLINE: Cannabidiol, Drug Resistant Epilepsy, Epilepsy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Institute of Neurological Disorders and Stroke, National Institutes of Health.
Abstract (Originalsprache)
Neuroinflammation (NI) is a key pathophysiological contributor to treatment-resistant epilepsy (TRE) that remains challenging to observe in vivo. Magnetic resonance spectroscopic imaging and thermometry (MRSI-t) is an emerging technique that can be used to non-invasively map brain temperature, whereby brain temperature elevations serve as a surrogate for the cellular and biochemical processes associated with NI. In a previous multimodal imaging study of focal epilepsy patients, we observed MRSI-t-based brain temperature elevations ipsilateral to the seizure onset zone (SOZ) that were concordant with evidence of edema (Sharma et al., 2023). Despite its potential as tool, it is unclear if MRSI-t can monitor changes in brain temperature in response to treatment. We imaged 25 participants approximately 12-weeks apart. Eight patients with TRE were imaged before receiving highly-purified pharmaceutical grade cannabidiol (CBD; pre-CBD) and after 12-weeks of CBD (on-CBD) therapy. Seventeen healthy controls (HCs) were also imaged twice. Repeated measures t-tests computed changes in TRE patients' seizure symptoms, mood, and brain temperature within their respective SOZs. Repeated measures ANOVAs tested Group*Time changes in imaging data. Participants with TRE had abnormally high peak brain temperatures within their SOZs that decreased after CBD initiation (p < 0.0001). Seizure severity scores also improved after CBD initiation (p < 0.001). These findings provide insights into the possible neural effects of CBD, and further demonstrate MRSI-t's potential as a tool for delineating SOZ. Further investigations into MRSI-t as a longitudinal measure of therapy-induced changes in NI are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA; Department of Neurobiology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA. Electronic address: ayushe.sharma@yale…
- Department of Neurology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA; Department of Neurobiology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA; Department of Neurosurgery, University…
Förderung
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Sharma, A. A., & Szaflarski, J. P. (2024). The longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2023.109606
Vancouver
Sharma AA, Szaflarski JP. The longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2023.109606
BibTeX
@article{Sharma2024,
author = {Sharma, Ayushe A and Szaflarski, Jerzy P},
title = {The longitudinal effects of cannabidiol on brain temperature in patients with treatment-resistant epilepsy},
journal = {Epilepsy & Behavior},
year = {2024},
doi = {10.1016/j.yebeh.2023.109606}
}
EUVIMED